NCT04944017 Ketamine for the Treatment of Depression in Parkinson's Disease Status COMPLETED Phase PHASE2
NCT04933513 Development and Validation of a Scale Measuring Preoperative Expectations in Parkinson's Disease Status COMPLETED Phase N/A
NCT04926909 Study on Serum Cystatin C and PET-DAT in Patients With Parkinson's Disease Status UNKNOWN Phase N/A
NCT04875962 A Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Patients With Parkinson's Disease (PD) Status COMPLETED Phase PHASE1
NCT04867642 A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease Status COMPLETED Phase PHASE1
NCT04837313 Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Parkinson's Disease With Constipation Status RECRUITING Phase NA
NCT04799470 Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease Status RECRUITING Phase NA
NCT04778176 Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients Status COMPLETED Phase PHASE2
NCT04735172 Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects Status RECRUITING Phase NA
NCT04726709 Poised for Parkinson's - an Intervention to Increase Embodied Agency in People With Parkinson's Disease and Their Carers Status COMPLETED Phase NA
NCT04652843 Single-center Pathophysiological Study of the Role of Inflammation, Changes in the Intestinal Epithelial Barrier and the Intestinal Microbiota in Parkinson's Disease Status TERMINATED Phase NA
NCT04651153 A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD) Status COMPLETED Phase PHASE1
NCT04617496 An RCT of a Telemedicine Intervention for Hypokinetic Dysarthria in PD Status COMPLETED Phase NA
NCT04611581 Objective Assessment of Behavioural Disorders in PD Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04593511 to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers Status UNKNOWN Phase PHASE1
NCT04584346 Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD) Status COMPLETED Phase PHASE1